As global awareness of gender-specific medicine continues to rise, the women's health therapeutics market is entering a ...

Type 1 diabetes is a lifelong condition in which the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. The loss of these cells leads to high blood sugar ...

Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next ...

We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

Pfizer Chief Executive Albert Bourla is equally worried. While agreeing on the need for a more secure drug supply, he doubts ...

BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest ...

Mileutis, a biopharmaceutical company leading the dairy industry and animal health into a sustainable future through antibiotic and hormone-free solutions, today announced the appointment of two new ...

First quarter 2025 total revenue of approximately $53.3 million, which includes net product sales of $43.6 million and contract revenues from collaborations of $9.8 ...

Q1 2025 Earnings Call Transcript May 7, 2025 Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $1.53 ...

The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for its impact on tackling obesity ...

In April, ProQR announced the appointments of Dennis Hom as Chief Financial Officer and Cristina Lopez Lopez, MD, PhD as Chief Medical Officer. These key leadership appointments support the ...